Blockchain Registration Transaction Record

GeoVax Advances US-Made Mpox Vaccine Amid Clade 1 Outbreak

GeoVax advances US-made mpox vaccine as Clade 1 cases emerge in California. EMA-endorsed GEO-MVA vaccine and domestic manufacturing address fragile supply chains.

The emergence of locally transmitted Clade 1 mpox in California represents a significant escalation in the public health threat, as this strain causes more severe illness than the previously circulating Clade 2. With the U.S. dependent on a single foreign manufacturer for mpox vaccines, this dependency creates critical vulnerabilities in pandemic response capabilities. GeoVax's development of a domestically manufactured alternative vaccine addresses national security concerns while providing surge capacity during outbreaks. The company's alignment with federal pandemic preparedness initiatives demonstrates how public-private partnerships can strengthen America's medical supply chain resilience, ensuring faster response times and reduced reliance on international manufacturers during health emergencies that could affect millions of Americans.